关注
Tai-Hsien Ou Yang
Tai-Hsien Ou Yang
Roche Innovation Center New York
在 roche.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
43702018
Development of a prognostic model for breast cancer survival in an open challenge environment
WY Cheng, TH Ou Yang, D Anastassiou
Science translational medicine 5 (181), 181ra50-181ra50, 2013
1472013
Biomolecular events in cancer revealed by attractor metagenes
WY Cheng, TH Ou Yang, D Anastassiou
PLoS Comput Biol 9 (2), e1002920, 2013
1412013
A community effort to create standards for evaluating tumor subclonal reconstruction
A Salcedo, M Tarabichi, SMG Espiritu, AG Deshwar, M David, NM Wilson, ...
Nature biotechnology 38 (1), 97-107, 2020
652020
An infrared range camera-based approach for three-dimensional locomotion tracking and pose reconstruction in a rodent
TH Ou-Yang, ML Tsai, CT Yen, TT Lin
Journal of neuroscience methods 201 (1), 116-123, 2011
652011
Mosquito vector monitoring system based on optical wingbeat classification
TH Ouyang, EC Yang, JA Jiang, TT Lin
Computers and Electronics in Agriculture 118, 47-55, 2015
542015
A crowdsourcing approach to developing and assessing prediction algorithms for AML prognosis
DP Noren, BL Long, R Norel, K Rrhissorrakrai, K Hess, CW Hu, ...
PLoS computational biology 12 (6), e1004890, 2016
352016
Cancer Genome Atlas Research
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, TH Ou Yang, ...
N., Lazar, AJ, Serody, JS, Demicco, EG, Disis, ML, Vincent, B. G …, 2018
252018
Breast Cancer Prognostic Biomarker Using Attractor Metagenes and the FGD3–SUSD3 Metagene
TH Ou Yang, WY Cheng, T Zheng, MA Maurer, D Anastassiou
Cancer Epidemiology Biomarkers & Prevention 23 (12), 2850-2856, 2014
252014
JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors
CP Miller, JD Thorpe, AN Kortum, CM Coy, WY Cheng, TH Ou Yang, ...
Cancer immunology research 2 (4), 301-306, 2014
242014
Meta-analysis of expression and methylation signatures indicates a stress-related epigenetic mechanism in multiple neuropsychiatric disorders
K Zhu, TH Ou Yang, V Dorie, T Zheng, D Anastassiou
Translational psychiatry 9 (1), 32, 2019
162019
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies
A Easton, ML Jensen, C Wang, PH Hagedorn, Y Li, M Weed, JE Meredith, ...
Molecular Therapy-Nucleic Acids 29, 625-642, 2022
122022
Discovering genome-wide tag SNPs based on the mutual information of the variants
A Elmas, TH Ou Yang, X Wang, D Anastassiou
PLoS One 11 (12), e0167994, 2016
112016
Creating standards for evaluating tumour subclonal reconstruction
A Salcedo, M Tarabichi, SMG Espiritu, AG Deshwar, M David, NM Wilson, ...
bioRxiv, 310425, 2018
72018
Multi-cancer molecular signatures and their interrelationships
WY Cheng, TH Ou Yang, H Shen, PW Laird, D Anastassiou
arXiv preprint arXiv:1306.2584, 2013
62013
Development of a prognostic model for breast cancer survival in an open challenge environment. Sci Transl Med. 2013; 5: 181ra50
WY Cheng, TH Ou Yang, D Anastassiou
42013
Locomotion analysis method and locomotion analysis apparatus
TT Lin, OUY Tai-Hsien, T Meng-Li, YEN Chen-Tung
US Patent 8,737,722, 2014
32014
Lack of UGT polymorphism association with idasanutlin pharmacokinetics in solid tumor patients
WV So, TH Ou Yang, X Yang, J Zhi
Cancer Chemotherapy and Pharmacology 83, 209-213, 2019
22019
Crowd-sourced benchmarking of single-sample tumour subclonal reconstruction
A Salcedo, M Tarabichi, A Buchanan, SMG Espiritu, H Zhang, K Zhu, ...
bioRxiv, 2022.06. 14.495937, 2022
12022
BCAM (breast cancer attractor metagenes): A new tool for assessing breast cancer prognosis
WY Cheng, TH Ou Yang, M Maurer, D Anastassiou
Cancer Research 74 (19 Supplement), 2878-2878, 2014
12014
系统目前无法执行此操作,请稍后再试。
文章 1–20